Tag: ribonucleic acid (rna) editing market share

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Ribonucleic Acid (RNA) Editing Industry Compare Between 2025 And 2029?

The ribonucleic acid (RNA) editing market size has experienced robust growth in recent years. This market is projected to expand from $16.10 billion in 2024 to $17.55 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.0%. The expansion observed in the past can be attributed to a burgeoning demand for transient and reversible editing methodologies, increased application in neurodegenerative disease investigations, the escalating prevalence of rare and orphan diseases, a developing interest in synthetic biology and bioengineering, and a rise in academic and translational research initiatives.

The ribonucleic acid (RNA) editing market is anticipated to experience substantial expansion over the coming years. This sector is projected to reach a value of $24.42 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.6%. This expected growth during the forecast period is primarily fueled by the increasing occurrence of genetic disorders, a heightened emphasis on personalized medicine, expanding applications in cancer treatment, ongoing advancements in delivery systems, and greater support from governmental and regulatory bodies. Significant trends foreseen for this period encompass technological breakthroughs in RNA editing platforms, progress in in vivo delivery technologies, continued technological development in sequencing and transcriptomics, innovations in transient gene modulation techniques, and evolutions in synthetic biology applications.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27407&type=smp

Which Industry Drivers Are Expected To Accelerate The Ribonucleic Acid (RNA) Editing Market From 2025 To 2029?

An anticipated increase in genetic disorders is poised to fuel the expansion of the ribonucleic acid (RNA) editing market in the future. These disorders are conditions resulting from alterations or defects in an individual’s genetic makeup, which can be passed down from parents or emerge without prior inheritance. The prevalence of genetic disorders is increasing, attributed to an aging parental population, given that older parents face an elevated risk of transmitting chromosomal irregularities. Ribonucleic acid (RNA) editing offers a therapeutic approach for genetic disorders by rectifying mutations at the RNA stage, thereby enabling cells to generate working proteins without modifying the fundamental DNA structure. As an illustration, data from May 2024, provided by the US-based public health agency, the Centers for Disease Control and Prevention (CDC), indicates that approximately 100,000 individuals in the United States are impacted by sickle cell disease (SCD). Consequently, the growing incidence of genetic disorders is serving as a primary impetus for the expansion of the ribonucleic acid (RNA) editing market.

What Are The Major Segment Types Covered In The Ribonucleic Acid (RNA) Editing Market?

The ribonucleic acid (RNA) editing market covered in this report is segmented

1) By Type: Messenger Ribonucleic Acid (RNA) Modification, Transfer Ribonucleic Acid (RNA) Modification, Ribosomal Ribonucleic Acid (RNA) Modification

2) By Technique: Insertion Or Deletion, Deamination

3) By Application: Cancer, Genetic Disorders, Temporary Maladies

Subsegments:

1) By Messenger Ribonucleic Acid (MRNA) Modification: Base Editing, Adenosine Deaminase Acting On Ribonucleic Acid (RNA)-Mediated Editing, Site-Directed Ribonucleic Acid(RNA) Editing

2) By Transfer Ribonucleic Acid (TRNA) Modification: Pseudouridylation, Transfer Ribonucleic Acid Splicing, Inosine Modification

3) By Ribosomal Ribonucleic Acid (Rrna) Modification: Pseudouridylation, Ribosomal Ribonucleic Acid (RNA) Maturation Pathway Modulation, Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing

Which Key Trends Are Expected To Influence The Ribonucleic Acid (RNA) Editing Market In The Coming Years?

Prominent companies operating in the ribonucleic acid (RNA) editing market are dedicating efforts to pioneering strategies, such as in vivo gene editing, to facilitate accurate and efficient correction of disease-causing mutations within living organisms. In vivo gene editing denotes the direct modification of genes inside a living being’s cells to rectify genetic abnormalities or alter gene activity for therapeutic application. For instance, in April 2024, the Rett Syndrome Research Trust, a US-based non-profit organization, inaugurated the MECP2 Editing Consortium to propel gene editing treatments for Rett syndrome. This endeavor unites six leading laboratories to devise DNA and RNA editing therapies that target the genetic basis of Rett syndrome, with the objective of accelerating their move towards clinical trials. Its cooperative framework fosters more rapid development by aggregating expertise to provide precise and potentially curative interventions for this serious neurological condition.

Which Global Market Leaders Are Shaping The Future Of The Ribonucleic Acid (RNA) Editing Sector?

Major companies operating in the ribonucleic acid (RNA) editing market are Moderna Inc., Arcturus Therapeutics Holdings Inc., CureVac AG, Beam Therapeutics Inc., EdiGene Inc., Ethris GmbH, Deep Genomics Incorporated, ProQR Therapeutics NV, ReCode Therapeutics, Capstan Therapeutics Inc., TriLink BioTechnologies, ADARx Pharmaceuticals Inc., Storm Therapeutics Limited, Ascidian Therapeutics Inc., Rznomics Inc., Airna Biotech S.L., hC Bioscience Inc., Korro Bio Inc., Shape TX, and Turn Biotechnologies.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-editing-global-market-report

How Does The Ribonucleic Acid (RNA) Editing Market Perform Across Key Geographic Regions?

North America was the largest region in the ribonucleic acid (RNA) editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Ribonucleic Acid (RNA) Editing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27407&type=smp

Browse Through More Reports Similar to the Global Ribonucleic Acid (RNA) Editing Market 2025, By The Business Research Company

Recycled Glass Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/recycled-glass-global-market-report

Container Glass Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/container-glass-global-market-report

Glass Substrate Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/glass-substrate-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Outlook for the Ribonucleic Acid (RNA) Editing Market Heading Into 2029?

The ribonucleic acid (RNA) editing industry has seen significant expansion recently, with projections showing an increase from $16.10 billion in 2024 to $17.55 billion in 2025 – a compound growth rate (CAGR) of 9.0%. This uptrend during the historic period is due to a rise in interest in transient and reversible editing techniques, greater utilization in neurodegenerative disease studies, increasing incidence of rare and orphan illnesses, heightened focus on synthetic biology and bioengineering, along with enhanced academic and translational research efforts.

Forecasting robust expansion in the coming years, the ribonucleic acid (RNA) editing market is set to reach $24.42 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%. The market’s expansion during this period is likely to be driven by factors such as a growing prevalence of genetic disorders, an increased emphasis on personalized medicine, a surge in cancer treatment applications, improvements in delivery system technology, and escalating support from government and regulatory bodies. Some significant trends contributing to this projection include technological enhancements in RNA editing platforms, evolution in in vivo delivery technologies, advancement in sequencing and transcriptomics, progression in transient gene modulation methods, and the emergence of synthetic biology applications.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27407&type=smp

Which Factors Are Pushing The Ribonucleic Acid (RNA) Editing Market Forward?

The growing prevalence of genetic disorders is set to drive the expansion of the ribonucleic acid (RNA) editing market. These disorders, stemming from alterations or mutations in genetic material either passed down from parents or emerging spontaneously, are on the rise, largely due to increased parental age. Older parents are more likely to pass on chromosomal irregularities. The RNA editing process can address these disorders by rectifying mutations at the RNA level. This allows cells to generate operational proteins without modifying the DNA underneath. As an example, in May 2024, the Centers for Disease Control and Prevention (CDC), a public health agency in the United States, revealed that around 100,000 people in the country suffer from sickle cell disease (SCD). As such, the increase in genetic disorders is fuelling the ribonucleic acid (RNA) editing market’s growth.

Which Segment Held The Largest Share In The Ribonucleic Acid (RNA) Editing Market In 2025?

The ribonucleic acid (RNA) editing market covered in this report is segmented

1) By Type: Messenger Ribonucleic Acid (RNA) Modification, Transfer Ribonucleic Acid (RNA) Modification, Ribosomal Ribonucleic Acid (RNA) Modification

2) By Technique: Insertion Or Deletion, Deamination

3) By Application: Cancer, Genetic Disorders, Temporary Maladies

Subsegments:

1) By Messenger Ribonucleic Acid (MRNA) Modification: Base Editing, Adenosine Deaminase Acting On Ribonucleic Acid (RNA)-Mediated Editing, Site-Directed Ribonucleic Acid(RNA) Editing

2) By Transfer Ribonucleic Acid (TRNA) Modification: Pseudouridylation, Transfer Ribonucleic Acid Splicing, Inosine Modification

3) By Ribosomal Ribonucleic Acid (Rrna) Modification: Pseudouridylation, Ribosomal Ribonucleic Acid (RNA) Maturation Pathway Modulation, Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing

How Are Key Trends Driving Expansion In The Ribonucleic Acid (RNA) Editing Industry?

The focus is on novel methodologies such as in vivo gene editing by key players in the ribonucleic acid (RNA) editing market, which allows for precise and effective remediation of disease-causing genetic alterations within living beings. In vivo gene editing is a cutting-edge technique that corrects genetic deformities or alters gene activity directly within an organism’s cells for therapeutic purposes. To illustrate, the Rett Syndrome Research Trust, an American non-profit organization, initiated the MECP2 Editing Consortium in April 2024 to expedite gene editing treatments for Rett syndrome. Six premier laboratories collaborate through this initiative to develop DNA and RNA editing therapies aimed at tackling the genetic roots of Rett syndrome, with the aim of hastening their progress towards clinical trials. This joint endeavor encourages swift advancement by harnessing collective expertise to provide accurate and potentially healing answers for this severe neurological disease.

Which Organizations Are Driving Progress In The Ribonucleic Acid (RNA) Editing Industry?

Major companies operating in the ribonucleic acid (RNA) editing market are Moderna Inc., Arcturus Therapeutics Holdings Inc., CureVac AG, Beam Therapeutics Inc., EdiGene Inc., Ethris GmbH, Deep Genomics Incorporated, ProQR Therapeutics NV, ReCode Therapeutics, Capstan Therapeutics Inc., TriLink BioTechnologies, ADARx Pharmaceuticals Inc., Storm Therapeutics Limited, Ascidian Therapeutics Inc., Rznomics Inc., Airna Biotech S.L., hC Bioscience Inc., Korro Bio Inc., Shape TX, and Turn Biotechnologies.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-editing-global-market-report

Which Region Is Expected To Experience The Highest Growth In The Ribonucleic Acid (RNA) Editing Industry?

North America was the largest region in the ribonucleic acid (RNA) editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=27407&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model